Metis Global Partners LLC Raises Stake in Healthcare Realty Trust Incorporated (NYSE:HR)

Metis Global Partners LLC lifted its stake in Healthcare Realty Trust Incorporated (NYSE:HR) by 11.4% during the fourth quarter, HoldingsChannel reports. The firm owned 41,624 shares of the real estate investment trust’s stock after purchasing an additional 4,249 shares during the period. Metis Global Partners LLC’s holdings in Healthcare Realty Trust were worth $706,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Sage Investment Counsel LLC bought a new position in Healthcare Realty Trust in the fourth quarter worth approximately $431,000. Proficio Capital Partners LLC bought a new position in shares of Healthcare Realty Trust during the 4th quarter worth $440,000. Bank of New York Mellon Corp grew its position in shares of Healthcare Realty Trust by 12.0% during the 4th quarter. Bank of New York Mellon Corp now owns 4,630,973 shares of the real estate investment trust’s stock worth $78,495,000 after buying an additional 495,599 shares in the last quarter. Impax Asset Management Group plc increased its stake in shares of Healthcare Realty Trust by 10.0% during the fourth quarter. Impax Asset Management Group plc now owns 440,000 shares of the real estate investment trust’s stock valued at $7,458,000 after buying an additional 40,000 shares during the period. Finally, Hudson Edge Investment Partners Inc. raised its holdings in shares of Healthcare Realty Trust by 22.1% in the fourth quarter. Hudson Edge Investment Partners Inc. now owns 39,185 shares of the real estate investment trust’s stock valued at $664,000 after acquiring an additional 7,101 shares in the last quarter.

Insider Activity at Healthcare Realty Trust

In related news, COO Robert E. Hull sold 10,000 shares of the company’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total value of $174,800.00. Following the transaction, the chief operating officer now directly owns 171,400 shares of the company’s stock, valued at $2,996,072. This represents a 5.51 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.56% of the stock is currently owned by insiders.

Healthcare Realty Trust Stock Down 0.6 %

NYSE:HR opened at $16.69 on Wednesday. The stock has a market capitalization of $5.86 billion, a price-to-earnings ratio of -9.38 and a beta of 0.94. Healthcare Realty Trust Incorporated has a 52 week low of $12.77 and a 52 week high of $18.90. The firm has a 50 day moving average of $16.63 and a 200 day moving average of $17.36.

Healthcare Realty Trust (NYSE:HR) last posted its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The firm had revenue of $309.77 million during the quarter, compared to analysts’ expectations of $303.81 million. During the same quarter last year, the firm earned $0.39 EPS. The business’s quarterly revenue was down 6.3% on a year-over-year basis. As a group, analysts expect that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.

Healthcare Realty Trust Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.31 per share. The ex-dividend date is Monday, March 3rd. This represents a $1.24 annualized dividend and a dividend yield of 7.43%. Healthcare Realty Trust’s dividend payout ratio (DPR) is currently -69.66%.

Wall Street Analysts Forecast Growth

HR has been the topic of several recent research reports. StockNews.com cut shares of Healthcare Realty Trust from a “hold” rating to a “sell” rating in a report on Wednesday. JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research note on Friday, December 20th. Wedbush reissued an “outperform” rating and issued a $16.00 price objective on shares of Healthcare Realty Trust in a research note on Thursday, February 20th. Jefferies Financial Group lowered Healthcare Realty Trust from a “buy” rating to a “hold” rating and lowered their target price for the stock from $19.00 to $17.00 in a report on Thursday, January 2nd. Finally, Scotiabank cut their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating on the stock in a report on Tuesday, February 25th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $17.20.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.